Summary
OC-125 is a monoclonal antibody raised against tumour cells from a patient with serous cystadenocarcinoma and reacting with an antigen CA-125 on the surface of ovarian epithelial cancer cells. We investigated whether immunohistochemical determination of CA-125 in cell samples from the peritoneal cavity could be used to discriminate between non-specific inflammatory changes in the mesothelium and malignant ovarian tumour cells. Three categories of patients were investigated: patients with disseminated serous or endometrioid ovarian carcinomas, patients with non-specific inflammatory changes in the peritoneal cavity and patients subjected to simple hysterectomy with no pathological changes in the mesothelium. In all cases of ovarian cancer CA-125 positive cells could be detected in the peritoneal fluid; none of the other categories showed positive reaction for CA-125. The results suggest that OC-125 may be a valuable adjunct in differentiating neoplastic from other cells in ascitic fluid from patients with some types of ovarian cancer.
Similar content being viewed by others
References
Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68:1331
Fleuren GJ, Nap M, Aalders JG, Trimbos JB, Bruijn HWA de (1987) Explanation of the limited correlation between tumor Ca-125 content and serum CA-125 antigen levels in patients with ovarian tumors. Cancer 60:2437–2442
Kabawat SE, Bast RC Jr, Bhan AK Jr, Welch WR, Knapp RC, Colvin RB (1983) Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC-125. Int J Gynecol Pathol 2:275–285
Nouwen EJ, Hendrix PG, Dauwe S, Eerdekens MW, Broe ME de (1987) Tumor markers in the human ovary and its neoplasms. Am J Pathol 126:230–242
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Skov, R.V., Bichel, P. OC-125 as a diagnostic aid in the cytological evaluation of ascitic cells in patients with ovarian carcinoma. Vichows Archiv A Pathol Anat 419, 59–62 (1991). https://doi.org/10.1007/BF01600153
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01600153